These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains. Schmidt ML, Lee VM, Forman M, Chiu TS, Trojanowski JQ. Am J Pathol; 1997 Jul; 151(1):69-80. PubMed ID: 9212733 [Abstract] [Full Text] [Related]
27. Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer's disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study. Rezaie P, Pontikis CC, Hudson L, Cairns NJ, Lantos PL. J Histochem Cytochem; 2005 Aug; 53(8):929-40. PubMed ID: 16055747 [Abstract] [Full Text] [Related]
30. Simultaneous changes in gray matter volume and white matter fractional anisotropy in Alzheimer's disease revealed by multimodal CCA and joint ICA. Ouyang X, Chen K, Yao L, Hu B, Wu X, Ye Q, Guo X, Alzheimer’s Disease Neuroimaging Initiative. Neuroscience; 2015 Aug 20; 301():553-62. PubMed ID: 26116521 [Abstract] [Full Text] [Related]
34. Quantitative distribution of parvalbumin, calretinin, and calbindin D-28k immunoreactive neurons in the visual cortex of normal and Alzheimer cases. Leuba G, Kraftsik R, Saini K. Exp Neurol; 1998 Aug 20; 152(2):278-91. PubMed ID: 9710527 [Abstract] [Full Text] [Related]
35. Regional distribution of brain gangliosides in Alzheimer's disease. Kalanj S, Kracun I, Rosner H, Cosović C. Neurol Croat; 1991 Aug 20; 40(4):269-81. PubMed ID: 1751644 [Abstract] [Full Text] [Related]
36. Changes of neurocalcin, a calcium-binding protein, in the brain of patients with Alzheimer's disease. Shimohama S, Chachin M, Taniguchi T, Hidaka H, Kimura J. Brain Res; 1996 Apr 15; 716(1-2):233-6. PubMed ID: 8738246 [Abstract] [Full Text] [Related]